The hidradenitis suppurativa (HS) market across the seven major pharmaceutical markets (7MM) is projected to grow from $1.84 ...

Japan’s Eisai and US biotech major Biogen have announced that the latest findings demonstrating the benefits of continuous ...

As Indian drug manufacturers cry foul over the surge of cheap Chinese pharmaceutical raw material imports, the Indian ...

UCB, Belgium’s largest drugmaker, today released financial results for first half 2025, showing total revenue in increased to ...

Ipsen (Euronext: IPN) has reported second-quarter sales of 901 million euros ($980 million), up 8% from the same period a ...

Moderna (Nasdaq: MRNA) has secured European clearance for its latest version of Spikevax (elasomeran) for individuals aged ...

US pharma major AbbVie is considering a $1-billion acquisition of Gilgamesh Pharmaceuticals, Bloomberg News reported on Wednesday, citing people familiar with the matter.

GSK (LSE: GSK) posted a 6% rise in second-quarter sales to £8 billion ($10.7 billion), ahead of analyst forecasts. Pre-tax ...

Swedish biotech Oncopeptides (Nasdaq Stockholm: ONCO) has entered into a partnership with Spanish pharmaceutical broker SD ...

Vinay Prasad has left his post at the US Food and Drug Administration (FDA) less than three months after joining the agency.

USA-based Madrigal Pharmaceuticals today announced that it has entered into an exclusive global license agreement with CSPC ...

Japanese drugmaker Takeda has announced earnings results for the first quarter of Japan’s fiscal year 2025, ending June 30.